The University of Texas at El Paso will serve as the North American base of operations for Aconity3D, one of the world’s emerging technology leaders in the production of 3D printing equipment, under a new agreement announced by the two organizations this summer.
The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes.
IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2018 IMV ServiceTrak™ awards in clinical analyzers. Sysmex America, Inc. was recognized for: Hematology: •Best System Performance •Best Customer Satisfaction •Best Service
For decades, microbiologists have done their work by hand even as robotics and automation began to improve other laboratory processes. Until recently, the delicate techniques necessary to introduce mechanisms to microorganism study and analysis have been challenging for these divisions to automate. Now that's changing.
Ortho Clinical Diagnostics announced that, for the third year in a row, the Ortho Care™ service and support program was the highest-ranked original equipment manufacturer for overall service performance in the diagnostics industry.
Performance Motion Devices today announced that its ATLAS® digital amplifiers, featuring the highest power density in the industry, can now be used with third party microprocessors or field programmable gate arrays (FPGAs) via Serial Peripheral Interface (SPI) communications.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it was selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test
Ortho Clinical Diagnostics received approval from the U.S. Food and Drug Administration for Ortho’s VITROS® Immunodiagnostic Products HBeAg Assay and the VITROS® Immunodiagnostic Products Anti-HBe Assay for use on the VITROS® 3600 Immunodiagnostic System and VITROS® 5600 Integrated System
Ortho Clinical Diagnostics announced that its VITROS® NEPHROCHECK® test received CE Mark. The VITROS® NEPHROCHECK® test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide
Ortho Clinical Diagnostics’ VITROS® XT 7600 Integrated System received CE Mark. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging and the potential to perform two separate lab tests simultaneously, Ortho introduces digital chemistry to clinical lab management
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will officially unveil the VITROS® XT 7600 Integrated System, now available in numerous countries that accept CE Mark, at the 2018 AACC Annual Scientific Meeting & Clinical Lab Expo
Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.
Responding to customer requirements to handle increased volumes in decentralized clinical testing, MedTest Dx today announced the introduction of its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and the launch of its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.
Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced today that it has entered into an agreement with US-based Janssen Pharmaceuticals, Inc. (hereinafter “Janssen”) to develop and commercialize an AMYLOID β 42/40 RATIO assay.
MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Brandwidth Solutions, LLC, a full-service marketing agency addressing science-based businesses, has been recognized as Best Specialist Life Science Marketing Agency 2018-Pennsylvania by AI Global Media.
SCIEX, a global leader in life science analytical technologies, advanced the accessibility of mass spectrometry in the clinical setting with new product introductions at AACC 2018. Today, SCIEX announced the launch of the new Topaz™ Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes, as well as the new automated Vitamin D 200A Assay Kit.
Hahn-Schickard enables complex clinical pictures to be diagnosed quickly and reliably directly at the point of care. The latest device generation allows the amplification of RNA and DNA by means of fast PCR in 20 - 25 minutes. This makes it possible, for example, to analyze a real patient sample fully automatically in 30 minutes. The device can also be used in the field of food analysis or environmental analysis.
NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services, announced today the launch of its in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality and clinical research services.
Equitech Enterprises Inc. is leading supplier of quality human blood, human blood components, and biological fluids to the research industry.
Neoteryx LLC today announced research recently published in the official peer-reviewed scientific journal of the European Federation of Clinical Chemistry and Laboratory Medicine, Clinical Chemistry and Laboratory Medicine. The research found that analysis of samples extracted from the company’s VAMS™ technology showed almost perfect agreement with results obtained from venous blood samples for HbA1c levels on a Tosoh G8 analyzer. The investigator-initiated clinical research study took place from June 2017 to January 2018 at Ghent University Hospital in Belgium. The study included 100 patients and was approved by the school’s Ethics Committee.
Neoteryx LLC, announced today the expansion of its patent-pending Mitra® Microsampling portfolio to now include a 30 µL tip size. The Mitra microsampling device which comes in a 10 µL, 20 µL and now 30 µL holds and transports a precise volume of blood typically collected from a finger prick.
Today, Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, in the form of the Mitra® microsampling device, to Alcala Labs of San Diego for a more efficacious, streamlined approach to monitor patients in recovery centers throughout the United States. By incorporating VAMS specimen collection and transportation technology into its CleanAssure™ clinical convenience kits and testing menu, Alcala Labs is the first to commercialize an offering to addiction recovery centers that analyzes a volumetrically accurate dried blood microsample collected from a simple finger prick to test for alcohol and opioids.
Magnefy offer an additional performance-driven solid phase for magnetic particle-based assays and isolations, including SPRI-based* total DNA isolation. (*Solid phase reversible immobilization, which features the isolation of high-purity nucleic acid in the presence of NaCl and PEG.)
Festo AACC 2018 News — Festo introduces a compact rotary gripping module for handling vial and bottle caps. Booth #462
Festo AACC 2018 News -- Festo introduces its next generation liquid handling/modular dossing system. Booth #462
Equitech-Bio, Inc will attend and participate in AACC 2018 at Booth #3971.
Dynex Technologies announced today it has finalized a supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to sell Dynex instruments to the global clinical market.
The University of California San Diego and Spin, the dockless personal mobility company, are announcing the results of a bikeshare partnership pilot program which was created to provide more than 36,000 students, faculty and staff with an affordable, equitable and eco-friendly way to get around campus.
IDEX Health & Science Announces Acquisition of Finger Lakes Instrumentation
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new handheld version of its FDA-cleared diagnostic test reader...
GenPrime Inc., a leading provider of digital technology platforms and lateral flow readers, has announced the development of a new high-throughput version of its FDA-cleared diagnostic test reader...
Web Industries Inc., a leading medical contract manufacturing organization (CMO), will highlight its commitment to building lasting relationships with medical device makers as well as enhanced manufacturing capabilities for lateral flow immunoassay (LFI) devices.
Artel, is featuring a new demonstration at the 70th AACC Annual Scientific Meeting (Jul. 29 – Aug. 2). They will demonstrate how combining volume verification technology with a precise automated liquid handler can provide an optimized NGS workflow – speeding the process and eliminating doubt.
epMotion 5075 NGS solution comes with a new set of software features that was specifically developed for NGS customer needs, like intelligent selection of single and 8-channel dispensing tools, flexible number of samples, reduced dead-volume, more worktable capacity, email notification and more.
Two new centrifuges from Eppendorf: the smaller benchtop centrifuges with up to 24 spaces herald a new era, while Eppendorf is simultaneously expanding the product range of its large refrigerated benchtop centrifuges with a particularly versatile, high-capacity variant.
ALPCO, a leading producer of research and clinical immunoassays, has announced the upcoming launch of its FDA Class I Exempt STELLUX® Chemi Glucagon ELISA.
Visiun, the leader in laboratory analytics, will be showcasing the latest advancements in laboratory analytics at the 2018 AACC Clinical Lab Expo. Visit Visiun at booth 4367 at McCormick Place in Chicago, Illinois, from July 31 – August 2 to discover why hundreds of laboratories across the United States and Canada select Visiun’s Performance Insight® as their tool of choice for laboratory analytics.
Biotin supplementation, in the common dosage of 10 mg per day, can interfere with immunoassays leading to incorrect laboratory results and the potential for clinical misinterpretation.
This year at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, we look forward to showing our latest u-CupTM product line of Point-of-Care Drug testing cups.
Artel, as the industry’s strongest proponent of the critical role of liquid handling in achieving optimized assay results and improved laboratory productivity, is featuring a new demonstration at the 70th AACC Annual Scientific Meeting in Chicago (July29th – August 2nd).
Biomat has added to its line of coated 96 well microplates a line of PCR supports
3rd AARDA Walk in metro Detroit area will feature speakers, exhibitors, free screenings, a "Kid Zone", and a Warrior's Walk around Milliken State Park and Harbor on the RiverWalk to raise awareness and funding for patient services and research.
AutoSorter™ 1200 is Yaskawa Motoman’s high-speed sorting instrument for pre- and post-analytic specimen processing.
Yaskawa Motoman offers track-based specimen processing solutions that improve speed, capacity and accuracy for labor-intensive, high throughput areas of the clinical diagnostic lab. These fully integrated pre- and post-analytic automation solutions can enable high-volume throughput with minimal staffing to meet the needs for moderate volume labs up to the largest commercial laboratory operations.
AutoSorter™ 2000BB is Yaskawa Motoman’s high-speed bulk sorter for high-volume commercial laboratories, providing maximum specimen throughput at up to 2,000 tubes/hr. It minimizes manual handling of specimens through bulk loading/unloading, and it reduces sequential sorting by fine sorting in one step.
Diener Precision Pumps plans to launch their new Silencer LD gear pump at the AACC exhibition in Chicago, July 31st - August 2nd. Booth 4409.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right